Home/Filings/4/0001209191-21-053702
4//SEC Filing

Patel Premal 4

Accession 0001209191-21-053702

CIK 0001828522other

Filed

Aug 26, 8:00 PM ET

Accepted

Aug 27, 6:19 PM ET

Size

9.2 KB

Accession

0001209191-21-053702

Insider Transaction Report

Form 4
Period: 2021-08-25
Patel Premal
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-08-25+424,911424,911 total
    Exercise: $2.08Exp: 2030-07-28Common Stock (424,911 underlying)
  • Award

    Earn-out Right

    2021-08-25+62,59362,593 total
    Common Stock (62,593 underlying)
Footnotes (3)
  • [F1]On August 25, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of May 26, 2021 (the "Merger Agreement"), by and among the Issuer (f/k/a Locust Walk Acquisition Corp.), Locust Walk Merger Sub, Inc. ("Merger Sub"), and eFFECTOR Therapeutics, Inc. ("Old eFFECTOR"), Merger Sub merged with and into Old eFFECTOR with Old eFFECTOR surviving as a wholly owned subsidiary of the Issuer (the "Merger"). Upon consummation of the Merger (the "Effective Time"), each outstanding option to purchase shares of old eFFECTOR common stock (each an "old eFFECTOR Option") was automatically cancelled and converted into an option to purchase a number of shares of common stock of the Issuer equal to (i) the number of shares of old eFFECTOR common stock subject to the applicable old eFFECTOR Option multiplied by (ii) approximately 0.09657, rounded down to the nearest whole share.
  • [F2]The stock option vests 25% on July 13, 2021, and in 36 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
  • [F3]Each earn-out right represents a contingent right to receive one share of the Issuer's common stock. Pursuant to an "Earn-Out" provision in the Merger Agreement, the earn-out rights vest upon the Issuer's common stock achieving a price per share which equals or exceeds $20.00 over at least 20 trading days out of a 30 consecutive trading day period prior to August 26, 2023.

Issuer

eFFECTOR Therapeutics, Inc.

CIK 0001828522

Entity typeother

Related Parties

1
  • filerCIK 0001879012

Filing Metadata

Form type
4
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 6:19 PM ET
Size
9.2 KB